Keyphrases
COVID-19
100%
Critically Ill Patients
94%
Denmark
63%
Randomized Trial
62%
Patients with COVID-19
59%
Nationwide Observational Study
56%
Sepsis
54%
Intensive Care Unit
48%
Randomized Controlled Trial
46%
Procalcitonin
45%
Confidence Interval
43%
Out-of-hospital Cardiac Arrest
42%
Intensive Care Unit Patients
42%
Induced Hypothermia
42%
Septic Shock
37%
ICU Patients
37%
Hazard Ratio
28%
Population-based Cohort Study
28%
Patient Data
28%
Intensive Care
27%
Mechanical Ventilation
24%
90-day Mortality
24%
Endothelial Damage
23%
ICU Admission
20%
Coronavirus Disease (COVID)
19%
Intensive Care Patients
19%
Length of Stay
18%
Long-term Survival
17%
Resource Use
17%
Comorbidity
15%
Bilirubin
15%
Bleeding Events
15%
Mean Arterial Pressure
14%
Thrombocytopenia
14%
Randomized Clinical Trial
14%
Sepsis Mortality
14%
Bloodstream Infection
14%
Antimicrobial
14%
Ventricular Arrhythmia
14%
Low-dose Hydrocortisone
14%
Guided Intervention
14%
Leukocytes
14%
Prognostic Factors
14%
Nonrecovery
14%
Injury Biomarkers
14%
ABO Blood Group
14%
High-dose Corticosteroids
14%
Guideline-directed Medical Therapy
14%
Blood Type
14%
C-reactive Protein
14%
Medicine and Dentistry
COVID-19
99%
Intensive Care Unit
92%
Observational Study
56%
Sepsis
55%
Intensive Care
46%
Biological Marker
41%
Septic Shock
35%
Induced Hypothermia
28%
Out of Hospital Cardiac Arrest
28%
Artificial Respiration
28%
Hazard Ratio
26%
Procalcitonin
25%
Antibiotics
23%
Infection
19%
Thrombomodulin
17%
Respiratory Failure
17%
Cohort Analysis
16%
Long Term Survival
15%
Thromboembolism
15%
Syndecan 1
15%
All Cause Mortality
15%
Hypoxia
14%
Acute Respiratory Failure
14%
Acute Respiratory Distress Syndrome
14%
Heart Arrest
14%
Functional Status
14%
Lung Injury
14%
Glucocorticoid
14%
Hydrocortisone
14%
Surfactant Protein D
14%
Low Drug Dose
14%
Atrial Fibrillation
14%
Targeted Temperature Management
14%
Open-Label Trial
14%
Thrombocyte Function
14%
Drug Megadose
14%
Prognostic Factor
14%
Acute Kidney Injury
14%
Hemodynamic
14%
Broad-Spectrum Antibiotic
14%
Restylane
14%
Arm
14%
Renal Failure
14%
Mean Arterial Pressure
12%
Bilirubin
11%
Charlson Comorbidity Index
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Renal Replacement Therapy
9%
Placebo
8%
Quality of Life
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
56%
Biological Marker
55%
Sepsis
49%
Coronavirinae
49%
Procalcitonin
45%
Out of Hospital Cardiac Arrest
42%
Cohort Study
35%
Antiinfective Agent
35%
Antibiotic Agent
34%
Randomized Controlled Trial
30%
Placebo
27%
Heart Arrest
18%
Antibiotics
18%
Thrombomodulin
17%
Infection
16%
All Cause Mortality
16%
Methylprednisolone
16%
Syndecan 1
15%
Frailty
14%
Acute Kidney Failure
14%
Hypoxia
14%
Randomized Clinical Trial
14%
Bilirubin
14%
Hyaluronic Acid
14%
Kidney Failure
14%
Heart Arrhythmia
14%
Meropenem
14%
Long Term Survival
14%
Thromboembolism
14%
Hydrocortisone
14%
Ciprofloxacin
14%
Candidiasis
14%
Functional Status
14%
Observational Study
14%
Thrombocytopenia
14%
Acute Respiratory Failure
14%
Glucocorticoid
14%
C Reactive Protein
14%
Cefuroxime
14%
Piperacillin Plus Tazobactam
14%
Bloodstream Infection
14%
Adult Respiratory Distress Syndrome
14%
Surfactant Protein D
14%
Lung Injury
14%
Interleukin 6
11%
Neuron Specific Enolase
11%
Clinical Trial
9%
SARS Coronavirus
9%
Antibiotic Therapy
8%
Septic Shock
7%